A Japanese Big Pharma client requested fast turn around on Key Opinion Leader (KOL) thoughts on high-priority competitor abstracts presented at international oncology conferences.
The Big Pharma client found the output particularly useful, so much so that they have since renewed the retainer multiple times, spanning several years.